Hjem › Uveal melanom › Tennessee
Uveal melanom kliniske forsøg i Tennessee
6 studier for Uveal melanom søger deltagere på steder i Tennessee.
Byer i Tennessee
Officiel studietekst (engelsk)
Study of Adjuvant Darovasertib and Crizotinib in Participants With Primary Non-metastatic Uveal Melanoma
- Sarah Cannon Research Institute (SCRI), Nashville
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 15. sep. 2026 · NCT07804186A Study to Investigate the Safety and Efficacy of IOV-3001 in Adults With Advanced Melanoma Who Will Receive Lifileucel
- Sarah Cannon Research Institute, Nashville
RekruttererFase 1/2
Alder 18 til 70 · Alle køn · Opdateret 15. jun. 2026 · NCT06940739Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
- The Sarah Cannon Research Institute/Tennessee Oncology, Nashville
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 8. jun. 2026 · NCT03947385Neoadjuvant Darovasertib in Primary Uveal Melanoma
- SCRI Oncology Partners, Nashville
- Vanderbilt Eye Institute, Nashville
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 6. maj 2026 · NCT07015190A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
- The West Clinic, PLLC dba West Cancer Center, Germantown
- University of Tennessee Medical Center, Knoxville
- Sarah Cannon Research Institute, Nashville
- og 1 flere
RekruttererFase 2/3
Alle aldre · Alle køn · Opdateret 2. apr. 2026 · NCT06581406Evaluation of the Safety, Efficacy, and Pharmacokinetics of NBM-BMX in Patients With Metastatic Uveal Melanoma
- SCRI Oncology Partners, Nashville
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 28. nov. 2025 · NCT07136181Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.